DiaMedica Therapeutics Inc DMAC

‎$‎5.99-0.19(-3.07%)(1D)

• Delayed prices by NASDAQ • in USD

Invest in DiaMedica Therapeutics Inc
Today

Create an eToro account to buy DMAC stock on a secure, user-friendly, multi-asset trading platform.

DiaMedica Therapeutics Inc DMAC

Buy DMAC

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

CITIC Securities Co Ltd

‎$‎26.90

+8.29%

1179.HK

H World Group Limited

Commvault Systems Inc.

‎$‎88.87

+10.25%

MAX

*Past performance is not an indication of future results

Jump to:

About DMAC >
How to Buy? >
Top Guides >

The DiaMedica Therapeutics Inc share price is stable this week.

The DiaMedica Therapeutics Inc price today is ‎$‎5.99, a ‎-3.07‎% change in the last 24 hours and ‎0‎% in the past week. DiaMedica Therapeutics Inc price changed by ‎0‎% in the past year.

DMAC Key Metrics

Market Cap

Day’s Range

‎$‎5.72 - ‎$‎6.12

52W Range

‎$‎5.72 - ‎$‎8.9

Average Volume (3M)

Price-Earnings Ratio

Revenue

Dividend (Yield)

Prev Close

‎$‎5.99

EPS

Beta

How can I buy DiaMedica Therapeutics Inc stocks?

To purchase DiaMedica Therapeutics Inc:

Create an eToro account:

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

Search and purchase:

Search the DiaMedica Therapeutics Inc (DMAC) page and place an order to buy DiaMedica Therapeutics Inc.

Buy DMAC

Looking for more information? Check out our guide on Academy.

What Is DiaMedica Therapeutics Inc?

DiaMedica Therapeutics Inc is a United States-based clinical-stage biopharmaceutical company developing protein-based therapies for neurological and renal disorders. The company focuses on conditions with significant unmet medical needs such as neurological and renal disorders.

Contributing to the biotechnology sector, DiaMedica Therapeutics Inc is focused on advancing its lead investigational therapy through clinical trials. Its research targets acute ischemic stroke and chronic kidney disease, with the goal of providing new treatment options.

Keep up to date on the latest share price changes by adding DMAC stock to your eToro watchlist.

This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.

CEO

Rick John Pauls, MBA

Employees

Founded

2000

Minneapolis, Minnesota, US

Med Tech

NASDAQ

Get Started

Top Guides

Our top picks for the most relevant guides from the eToro Academy

Top Dividend Stocks for 2026

Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.

Stock Trading And Investing For Beginners

Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.

AI Stocks Poised for Growth in 2026

Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.

Go to the Academy >

Invest in DiaMedica Therapeutics Inc
Today

Create an eToro account to buy DMAC stock on a secure, user-friendly, multi-asset trading platform.

Get Started

FAQ

What is the current price of DiaMedica Therapeutics Inc stock?

The current price of DMAC is ‎$‎5.99.

What are analysts’ forecasts for DiaMedica Therapeutics Inc?

Analysts offer forecasts for DiaMedica Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.

What is the market cap of DiaMedica Therapeutics Inc?

The market capitalisation of DiaMedica Therapeutics Inc is (The data is unavailable right now)

Daily Movers

Explore the biggest stocks movers on the market.